Aragon Pharmaceuticals Receives $22,000,000 Series B Financing

  • Feed Type
  • Date
    4/23/2010
  • Company Name
    Aragon Pharmaceuticals
  • Mailing Address
    4215 Sorrento Valley Blvd. San Diego, CA 92121
  • Company Description
    Aragon Pharmaceuticals is a San Diego based biopharmaceutical company focused on developing a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers.
  • Website
    http://www.aragonpharmaceuticals.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $22,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    This financing will allow us to advance ARN-509 into clinical trials and continue the discovery and development of selective androgen receptor degraders and selective estrogen receptor degraders for the treatment of prostate and breast cancers.
  • M&A Terms
  • Venture Investor
    Aisling Capital
  • Venture Investor
    OrbiMed
  • Venture Investor
    The Column Group

By posting a comment, you agree to our terms and conditions.